Intratumoral heterogeneity of CSNK1G3 mutations, a casein kinase 1, in colon cancers

首页> 外文期刊>Pathology Research and Practice >Intratumoral heterogeneity of CSNK1G3 mutations, a casein kinase 1, in colon cancers

【24h】

Intratumoral heterogeneity of CSNK1G3 mutations, a casein kinase 1, in colon cancers

机译：CSNK1G3突变的肿瘤内异质性，酪蛋白激酶1，在结肠癌中

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Pathology Research and Practice》 |2020年第5期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类病理学;
关键词
CSNK1G3; Casein kinase 1; Mutation; Cancer; Intratumoral heterogeneity;

机译：csnk1g3;酪蛋白激酶1;突变;癌症;肿瘤内异质性;

相似文献

外文文献
中文文献
专利

1. Intratumoral heterogeneity of CSNK1G3 mutations, a casein kinase 1, in colon cancers [J] . Pathology Research and Practice . 2020,第5期

机译：CSNK1G3突变的肿瘤内异质性，酪蛋白激酶1，在结肠癌中
2. Intratumoral Heterogeneity of Somatic Mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in Colon Cancers [J] . Eun Ji Choi, Ju Hwa Lee, Min Sung Kim, Pathology oncology research: POR . 2018,第4期

机译：在结肠癌中，NRIP1，DOK1，ULK1，ULK2，DLGAP3，PARD3和PRKCI的体细胞突变的肿瘤异质性
3. Intratumoral Heterogeneity for Expression of Tyrosine Kinase Growth Factor Receptors in Human Colon Cancer Surgical Specimens and Orthotopic Tumors [J] . Toshio Kuwai* Toru Nakamura* Sun-Jin Kim* Takamitsu Sasaki* Yasuhiko Kitadai* Robert R. Langley* Dominic Fan* Stanley R. Hamilton and Isaiah J. Fidler* American Journal of Pathology . 2008,第2期

机译：肿瘤内异质性表达人结肠癌手术标本和原位肿瘤中酪氨酸激酶生长因子受体的表达
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity [O] . Seraina Faes, Nicolas Demartines, Olivier Dormond 2017

机译：在癌症治疗中对mTORC1抑制剂的耐药性：从激酶突变到激酶活性的肿瘤内异质性。
7. Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity. [O] . Faes, S., Demartines, N., Dormond, O. 2017

机译：在癌症治疗中对mTORC1抑制剂的耐药性：从激酶突变到激酶活性的肿瘤内异质性。

Intratumoral heterogeneity of CSNK1G3 mutations, a casein kinase 1, in colon cancers

著录项

引文网络

相似文献

相关主题

期刊订阅